Health Care & Life Sciences » Biotechnology | LegoChem Biosciences Inc.

LegoChem Biosciences Inc. | Balance Sheet

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Cash & Short Term Investments
20,048
29,031
19,099
32,244
23,215
Total Accounts Receivable
806
410
9,577
13,173
15,960
Inventories
-
-
1
439
936
Other Current Assets
233
1,177
944
3,766
5,098
Total Current Assets
21,086
30,618
29,620
49,622
45,209
Net Property, Plant & Equipment
1,200
1,159
3,491
6,866
7,846
Total Investments and Advances
-
1,122
1,469
3,903
3,916
Long-Term Note Receivable
-
-
-
100
100
Intangible Assets
58
123
32,865
26,768
22,821
Other Assets
810
734
995
2,292
2,346
Total Assets
23,154
33,755
68,440
89,551
82,238
ST Debt & Current Portion LT Debt
-
-
1,800
6,174
6,704
Accounts Payable
245
274
6,060
7,570
9,117
Income Tax Payable
-
-
51
-
-
Other Current Liabilities
1,649
653
1,275
1,257
1,819
Total Current Liabilities
1,894
927
9,186
15,001
17,640
Long-Term Debt
1,051
9,069
9,829
7,853
8,519
Provision for Risks & Charges
1,561
2,075
1,654
2,180
2,545
Deferred Taxes
-
1,025
3,935
3,922
3,357
Other Liabilities
-
-
13
535
711
Total Liabilities
4,506
13,096
24,617
29,490
32,773
Common Equity (Total)
18,084
20,044
43,178
60,060
48,206
Total Shareholders' Equity
18,084
20,044
43,178
60,060
48,206
Total Equity
18,084
20,044
43,178
60,060
49,465
Liabilities & Shareholders' Equity
23,154
33,755
68,440
89,551
82,238
Accumulated Minority Interest
-
-
-
-
1,259
Non-Equity Reserves
564
616
645
-
-

About LegoChem Biosciences

View Profile
Address
8-26 Munpyeongseo-ro
Daejeon DE 34302
Korea, Republic Of
Employees -
Website http://www.legochembio.com
Updated 09/14/2018
LegoChem Biosciences, Inc. engages in the development and manufacturing of pharmaceuticals. Its main therapeutic areas include antibiotics, anti-coagulants, oncology, antibody-drug conjugate and protein-drug conjugate. The company was founded on May 2, 2006 and is headquartered in Daejeon, South Korea.